Edwards Lifesciences (EW) Change in Cash (2009 - 2026)

Edwards Lifesciences' Change in Cash history runs 18 years deep, the most recent figure standing at -$492.0 million for Q1 2026.

• On a quarterly basis, Change in Cash fell 646.67% year-over-year to -$492.0 million in Q1 2026; TTM through Mar 2026 was -$701.3 million, a 136.53% decrease from a year earlier, with the FY2025 full-year figure at -$119.3 million, down 106.24% from the prior year.
• Change in Cash slipped to -$492.0 million in Q1 2026 per EW's latest filing, from $244.7 million in the prior quarter.
• Across five years, Change in Cash topped out at $2.0 billion in Q3 2024 and bottomed at -$624.6 million in Q4 2024.
• The 5-year median for Change in Cash is $103.8 million (2023), against an average of $92.9 million.
• Across the five-year window, Change in Cash jumped 1905.38% in 2022 and sank 646.67% in 2026, its largest moves.
• Year by year, Change in Cash stood at -$479.1 million in 2022, then soared by 44.5% to -$265.9 million in 2023, then tumbled by 134.9% to -$624.6 million in 2024, then soared by 139.18% to $244.7 million in 2025, then sank by 301.06% to -$492.0 million in 2026.
• Per Business Quant, the three latest EW Change in Cash figures stand at -$492.0 million (Q1 2026), $244.7 million (Q4 2025), and -$595.2 million (Q3 2025).